Lateral Bony Wall Repositioning in Maxillary Sinus Floor Augmentation
Hungary40 participantsStarted 2017-03-01
Plain-language summary
The aim of the present prospective randomized controlled study is to clinically and histologically investigate the safety and efficacy of bony wall repositioning compared to rotary window preparation with membrane coverage in maxillary sinus floor augmentation.
Who can participate
Age range18 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* at least one missing maxillary premolar or molar
* at least 7 mm crestal bone width confirmed by preoperative ConeBeam Tomography (CBCT)
* maximally 5 mm residual bone height at the sinus floor confirmed by preoperative ConeBeam Tomography (CBCT)
* full mouth plaque and bleeding scores (FMPS and FMBS) \<20%
* satisfactory patient compliance (e.g. to participate in follow-up procedures)
* signed informed consent.
Exclusion Criteria:
* clinically relevant diseases (e.g.: diabetes, rheumatism cancer)
* untreated periodontitis
* systemic steroid use
* bisphosphonate use
* acute or chronic inflammatory processes
* previous endoscopic sinus surgery
* previous sinus floor elevation
* GBR-treatment at the study site
* GTR-treatment at the study site
* tooth removal within 6 weeks prior to surgery